English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe TSA just reported an all-time high for the number of airline travelers screened, and major U.S. airlines expect to transport 271 million passengers this summer, a 6.3 percent increase from last year. Now, board-certified infectious disease physician Carl Abraham, M.D., assistant…
Tag: Immunocompromised
An anti-inflammatory curbs spread of fungi causing serious blood infections
Study finds that mesalamine, a common anti-inflammatory drug, can fight the fungus Candida albicans in the gut, potentially preventing the risk of invasive candidiasis in patients with blood cancers.
Newly identified yeast could prevent fungal infections by outcompeting rivals, study suggests
Researchers at the Weizmann Institute of Science in Israel have identified a yeast that could be used to prevent invasive candidiasis, a major cause of death in hospitalized and immunocompromised patients. The study, to be published March 18 in the Journal of Experimental Medicine (JEM), shows that the novel yeast lives harmlessly in the intestines of mice and humans and can displace the yeast responsible for candidiasis, Candida albicans.
Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.
Study suggests longer time between COVID-19 vaccines more effective for some
A recent Houston Methodist study may offer some guidance on when certain populations should get their next booster. A research team of computational medicine and data scientists from the Houston Methodist Research Institute predicted the immune response to COVID-19 vaccines with a math model they developed, and also found that current CDC dosing intervals may require customization to protect all individuals alike.
UNLV, SNWA Study Makes Case for Candida Auris Wastewater Surveillance
A rapid spike in cases of a potentially deadly, drug-resistant fungus has concerned public health officials across the nation. But a team of Southern Nevada researchers hope their new study applying wastewater surveillance can help health officials get a step ahead of this emerging global public health threat.
Mount Sinai Researchers Develop a Rapid Test to Measure Immunity to COVID-19
Mount Sinai researchers have developed a rapid blood assay that measures the magnitude and duration of someone’s immunity to SARS-CoV-2, the virus that causes COVID-19. This test will allow large-scale monitoring of the population’s immunity and the effectiveness of current vaccines to help design revaccination strategies for vulnerable immunosuppressed individuals, according to a study published in Nature Biotechnology in June.
Suffering from Surge Stress? 9 Things to Do Right Now
For people who are “doing everything right” or who face a high risk of severe illness if they get COVID-19 during the current surge, this is a stressful time. A psychiatrist offers tips for recognizing the emotional effects and offers steps to help get through this time.
Immunocompromised More Likely to Have Breakthrough Cases, Hospitalization; Masking, COVID-19 Vaccination Critical to Protect Those at High Risk
Today, the American College of Chest Physicians (CHEST), American Lung Association and American Thoracic Society released the following statement in response to the increase in COVID-19 cases and hospitalizations.
Persistent COVID-19 infections in immunocompromised people may give rise to variants of concern
In an article in the New England Journal of Medicine, scientists from Fred Hutchinson Cancer Research Center, Johns Hopkins Bloomberg School of Medicine, the U.S. Military HIV Research Program and the Institute for Global Health and Infectious Diseases at the University of North Carolina urged increased attention to persistent COVID-19 infections in immunocompromised people.
For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
In a study published today in the Annals of Internal Medicine, Johns Hopkins Medicine researchers say they believe that, for the first time, there is evidence to show that three doses of vaccine increase antibody levels against SARS-CoV-2 — the virus that causes COVID 19 — more than the standard two-dose regimen for people who have received solid organ transplants.
Organ Transplant Recipients Remain Vulnerable to Covid-19 Even After Second Vaccine Dose
In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 — the virus that causes COVID 19 — confers some protection for people who have received solid organ transplants, it’s still not enough to enable them to dispense with masks, physical distancing and other safety measures.